STOCK TITAN

Hims & Hers Health director converts awards to 810 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. director Christopher D. Payne reported an RSU-to-share conversion involving 810 RSUs and 810 Class A common shares on November 13, 2026; his direct holdings afterward were 35,673 shares. The accompanying note says the RSUs were granted in lieu of $23,125 in third-quarter 2026 director retainer fees, calculated using a $28.53 grant price, and will vest in full on the company’s next quarterly vesting date. A separate holding entry lists 110,000 Class A shares held by The Payne Family Trust dtd 09/17/2020.

Insider Payne Christopher D
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Unit F1 810 $0.00 $0.00
Exercise Class A Common Stock F1 810 -- --
Holding Class A Common Stock -- -- --
Holdings After Transaction: Restricted Stock Unit — 0 units (Direct); Class A Common Stock — 35,673 shares (Direct); Class A Common Stock — 110,000 shares (Indirect, Held by The Payne Family Trust dtd 09/17/2020)
Holdings Before and After: Restricted Stock Unit, 810 to 0 units (Direct); Class A Common Stock, 34,863 to 35,673 shares (Direct)
Footnotes (1)
  1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the third quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,125 by the grant price of $28.53. The RSUs will vest in full on the Company's next quarterly vesting date.
Class A shares acquired 810 shares Reported conversion on November 13, 2026
Direct shares following transaction 35,673 shares Christopher D. Payne's reported direct holdings after the transaction
Trust-held shares 110,000 shares Class A shares held by The Payne Family Trust dtd 09/17/2020
Foregone director retainer fees $23,125 Third-quarter 2026 fees exchanged for RSUs
Grant price $28.53 Price used to calculate the RSU grant
Restricted Stock Units technical
"granted Restricted Stock Units which represent a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Director Compensation Policy financial
"pursuant to the Issuer's Director Compensation Policy"
grant price financial
"foregone cash fees divided by the grant price"
quarterly vesting date technical
"will vest in full on the Company's next quarterly vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HIMS shares did director Christopher D. Payne acquire?

The transaction records show the conversion of 810 RSUs into 810 Class A common shares on November 13, 2026, with 35,673 shares held directly afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Payne Christopher D

(Last)(First)(Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CALIFORNIA 94123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/13/2026M810A(1)35,673D
Class A Common Stock110,000IHeld by The Payne Family Trust dtd 09/17/2020
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)11/13/2026M810 (1) (1)Class A Common Stock810$00D
Explanation of Responses:
1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the third quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,125 by the grant price of $28.53. The RSUs will vest in full on the Company's next quarterly vesting date.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Christopher D Payne11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading